Correction to: Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer
Crossref DOI link: https://doi.org/10.1007/s40265-020-01436-3
Published Online: 2020-11-13
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Text and Data Mining valid from 2020-11-13
Version of Record valid from 2020-11-13
Article History
First Online: 13 November 2020
Free to read: This content has been made available to all.